Introduction
Interstitial Lung Disease (ILD) is an umbrella term for a large group of disorders that cause scarring (fibrosis) of the lungs. The scarring makes the lungs stiff, which makes it difficult to breathe and get enough oxygen into the bloodstream. Once lung scarring occurs, it is generally irreversible.
Symptoms
- Shortness of breath (worsening over time)
- Dry, hacking cough
- Fatigue
- Unexplained weight loss
- "Clubbing" (widening and rounding of the tips of fingers or toes)
Causes & Risk Factors
- Autoimmune diseases (like Rheumatoid Arthritis or Scleroderma)
- Exposure to organic or inorganic dust (Silicosis, Asbestosis)
- Certain medications and radiation therapy
- Idiopathic (no known cause, as in Idiopathic Pulmonary Fibrosis)
- Smoking and genetics
Our Treatment Approach at GHCCD
Diagnosis of ILD at GHCCD is a meticulous process involving High-Resolution CT (HRCT) and advanced Pulmonary Function Tests (including DLCO) to measure how well your lungs transfer oxygen. Our specialized ILD Clinic provides access to modern antifibrotic medications that can slow the progression of scarring.
We focus on a multidisciplinary approach, combining medication with Pulmonary Rehabilitation and oxygen therapy where needed. For end-stage ILD, we provide supportive care and facilitate evaluations for the Jeevandhan Lung Transplant program.
When to Visit GHCCD
Consult us if you experience a persistent dry cough or feel unusually breathless during exercise that was previously easy for you.
FAQ
Q: Can ILD be treated for free at GHCCD? A: Yes, GHCCD provides comprehensive diagnostic workups and essential treatments for ILD, including antifibrotic therapies, free of charge.
Patient informationMore about this service
Interstitial Lung Disease
Interstitial Lung Disease
Interstitial Lung Disease (ILD) refers to a group of over 200 chronic lung disorders characterized by inflammation and scarring (fibrosis) of the interstitium, the tissue and space around the air sacs (alveoli) in the lungs. This scarring thickens the interstitium, making it harder for oxygen to pass into the bloodstream, which results in symptoms like persistent dry cough, shortness of breath, and fatigue. ILD can be caused by long-term exposure to hazardous substances such as asbestos, silica dust, or certain gases, autoimmune diseases like rheumatoid arthritis, or have no identifiable cause, in which case it is referred to as idiopathic. The progression of ILD can vary widely, from slow and gradual to rapidly worsening, and its impact on lung function can significantly affect a patient’s quality of life.
Treatment for Interstitial Lung Disease
Treatment for Interstitial Lung Disease focuses on managing symptoms, slowing the progression of the disease, and improving the patient’s quality of life. Anti-inflammatory and immunosuppressive medications, such as corticosteroids and drugs like nintedanib or pirfenidone, are often used to reduce inflammation and fibrosis. Oxygen therapy may be necessary to help patients with advanced disease maintain adequate oxygen levels. Pulmonary rehabilitation, including exercise training, breathing techniques, and nutritional support, can help improve physical endurance and lung function. In some severe cases, lung transplantation may be considered for eligible patients. Regular monitoring and a personalized treatment plan are essential, as the response to treatment can vary depending on the specific type and progression of ILD.
